姓　　名：李环球
职称职务：副教授,硕士生导师
联系电话：**
电子邮箱：huanqiuli@suda.edu.cn
办公地址：云轩楼1324
个人简介：
一、学习工作经历
1、学历背景：
2004.9－2008.9南京大学生命科学院,硕博连读,理学博士
2000.9－2004.7吉林大学生物与农业工程学院,工学学士
2、工作经历：
2014.3－2015.5 美国新墨西哥大学化学与化学生物系，访问****
2011.3－ 今 苏州大学医学部药学院，副教授
2008.9 -2010.12 南京大学化学化工学院，博士后
二、研究方向
（1）基于多靶点的急性痛风性关节炎药物的设计与合成
（2）靶向抗癌先导药物的设计与合成
（3）计算机辅助药物设计研究
三、主要成绩及研究成果
从事靶向小分子药物的设计与合成、天然活性物质的结构改造及化学生物学等领域的研究，在靶向小分子药物的设计与合成方向具有丰富的经验，在多个药物化学和化学生物学国际期刊ACS Synthetic. Biology, Expert. Opin. Ther. Patents,Bioconjugate Chemistry,ChemMedChem, Eur. J. Med. Chem.,Bioorg. Med. Chem.及Bioorg. Med. Chem. Lett.上以通讯或第一作者发表关于小分子药物的设计合成及其生物活性方面的论文30余篇；获批或申请国家发明专利8项。目前支持在研或已完成国家青年自然科学基金、江苏省自然科学基金，江苏省高校自然科学基金、中国博士后基金特别资助、中国博士后基金和苏州市科技计划等多项科研项目；作为技术骨干（排名第二）参与国家自然科学基金课题五项。在2008年以第二完成人获得教育部自然科学二等奖：“市场药物及天然活性物质的结构改造、结构分析及其生物活性研究”。同时担任Journal of Medicinal Chemistry、Current Medicinal Chemistry、Bioorganic & Medicinal Chemistry等多个药物化学杂志的审稿人。
代表性论文
1. Huanqiu Li, Guihua Zeng, Yongyi Wei, Weimin Xuan, Roushu Zhang, Larisa E. Breden, Wei Wang, Fu-Sen Liang. Engineering Iron Responses in Mammalian Cells by Signal-Induced Protein. ACS Synthetic Biology,2017,6(6):921-927.
2. Qinghua Hu, Mengze Zhou, Haoran Zhu, Guo Lu, Dongsen Zheng, Huanqiu Li*, Kun Hao, (E)-2-(4-bromophenyl)-1-(2, 4-dihydroxyphenyl)ethanone oxime is a potential therapeutic agent for treatment of hyperuricemia through its dual inhibitory effects on XOD and URAT1. Biomed Pharmacother2017, 86:88-94.
3. Gui-Zhen Ao, Meng-Ze Zhou, Yu-Yao Li, Si-Ning Li, Hua-Nian Wang, Qian-Wen Wan, Huan-Qiu Li*, Qing-Hua Hu*, Discovery of novel curcumin derivatives targeting xanthine oxidase and urate transporter 1 as anti-hyperuricemic agents.Bioorg Med Chem2017, 25:166-174.
4. Qin, H. T.; Li, H. Q.^*; Liu, F*. Selective histone deacetylase small molecule inhibitors: recent progress and perspectives，Expert. Opin. Ther. Patents., 2017,27(5):621.
5. Weimin Xuan, Rong Pan, Yongyi Wei, Yanting Cao, Huanqiu Li, Fusen Liang, Kejian Liu, Wei Wang. Reaction-Based “Off–On” Fluorescent Probe Enabling Detection of Endogenous Labile Fe2+and Imaging of Zn2+-induced Fe2+Flux in Living Cells and Elevated Fe2+in Ischemic Stroke.Bioconjugate Chem2016,27(2):302-308.
6. Li, S. N.; Xu, Y. Y.; Gao, J. Y.; Yin, H. R.; Zhang, S. L.; Li, H. Q.^*Combination of 4-anilinoquinazoline and rhodanine as novel epidermal growth factor receptor tyrosine kinase inhibitor,Bioorg Med Chem, 2015, 23:3221-3227.
7. Li, S. N.; Li, H. Q.^*Epidermal Growth Factor Receptor (EGFR) inhibitors: a patent review (2010 - present),Expert. Opin. Ther. Patents.2014, 24(3): 309-321.
8. Song, H.; Ao, G. Z.; Li, H. Q.^*Novel FabH inhibitors: a updated article literature review(July 2012 to June 2013),Expert. Opin. Ther. Patents.2014, 24(1): 19-27.
9. Yun-Yun Xu, Yi Cao, Hailkuo Ma, Huan-Qiu Li* Gui-zhen Ao，Design, synthesis and molecular docking of alpha & beta-unsaturated cyclohexanone analogous of curcumin as potent EGFR inhibitors with antiproliferativeactivity.Bioorg Med Chem2013, 21,388-394.
10. Xu,Y. Y.; Li, S. N.; Yu, G. J.; Hu, Q. H.; Li, H. Q.^*Discovery of novel 4-anilinoquinazoline derivatives as potent inhibitors of epidermal growth factor receptor with antitumor activity, Bioorg Med Chem, 2013, 21:6084-6091.
11. Haikuo Ma, Huan-Qiu Li, Xiaohu Zhang*.Cyclopamine, a Naturally Occuring Alkaloid, and Its Analogues May Find Wide Applications in Cancer Therapy. Curr Top Med Chem2013, 13:2208-2215.
12. Huan-Qiu Li, Jing Yang, Shu-Hua Ma, Chun-Hua Qiao. Structure-Based Design of Rhodanine-based Acylsulfonamide Derivatives as Antagonists of the Anti-apoptotic Bcl-2 Protein. Bioorg Med Chem2012, 20:4194-4200.
13. Huan-Qiu Li*, Dong- Dong Li, Xiang Lu, Hai-Liang Zhu.Design and synthesis of 4,6-substituted-(diaphenylamino)quinazolines as potent EGFR inhibitors with antitumor activity.Bioorg Med Chem2012, 20:317-323.
14. Huan-Qiu Li*, Chun-Hua Qiao*. The Mechanisms of Anticancer Agents by Genistein and Synthetic Derivatives of Isoflavone. Mini-Rev Med Chem2012, 12:350-362.